ID: ALA3989198

Max Phase: Preclinical

Molecular Formula: C18H19Cl2N5O2

Molecular Weight: 408.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1nn2c(=O)cc(N3CCO[C@H](C)C3)nc2n1Cc1cccc(Cl)c1Cl

Standard InChI:  InChI=1S/C18H19Cl2N5O2/c1-11-9-23(6-7-27-11)15-8-16(26)25-18(21-15)24(12(2)22-25)10-13-4-3-5-14(19)17(13)20/h3-5,8,11H,6-7,9-10H2,1-2H3/t11-/m1/s1

Standard InChI Key:  XAWLMFFLUSASPB-LLVKDONJSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 408.29Molecular Weight (Monoisotopic): 407.0916AlogP: 2.78#Rotatable Bonds: 3
Polar Surface Area: 64.66Molecular Species: NEUTRALHBA: 7HBD: 0
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.42CX LogD: 3.42
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.67Np Likeness Score: -1.98

References

1. Simon Townson and Suzanne Gokool. GlaxoSmithKline Published Kinase Inhibitor Set 2 Onchocerca lienalis Screening Data,  [10.6019/CHEMBL3988181]